Pharming Group N.V.
PHARM.AS · AMS
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | €53 | €62 | €207 | €192 |
| Short-Term Investments | €109 | €152 | €0 | €0 |
| Receivables | €48 | €43 | €20 | €16 |
| Inventory | €54 | €57 | €42 | €27 |
| Other Curr. Assets | €5 | €14 | €3 | €3 |
| Total Curr. Assets | €269 | €316 | €278 | €249 |
| Property Plant & Equip (Net) | €23 | €33 | €39 | €33 |
| Goodwill | -€0 | €0 | €0 | -€0 |
| Intangibles | €59 | €71 | €75 | €84 |
| Long-Term Investments | €4 | €9 | €10 | €10 |
| Tax Assets | €31 | €30 | €23 | €21 |
| Other NC Assets | €1 | €3 | €1 | -€0 |
| Total NC Assets | €118 | €147 | €148 | €148 |
| Other Assets | €0 | €0 | €0 | €0 |
| Total Assets | €387 | €463 | €426 | €397 |
| Liabilities | – | – | – | – |
| Payables | €10 | €15 | €6 | €5 |
| Short-Term Debt | €7 | €5 | €5 | €2 |
| Tax Payable | €3 | €6 | €2 | €2 |
| Deferred Revenue | €0 | €0 | -€0 | -€0 |
| Other Curr. Liab. | €54 | €52 | €42 | €32 |
| Total Curr. Liab. | €74 | €78 | €60 | €47 |
| LT Debt | €101 | €166 | €153 | €141 |
| Deferred Rev, NC | €0 | €0 | €0 | €0 |
| Deferred Tax Liab, NC | €0 | €0 | €0 | €0 |
| Other NC Liab. | €0 | €0 | €9 | €17 |
| Total NC Liab. | €101 | €166 | €161 | €157 |
| Other Liabilities | -€3 | €0 | €0 | €0 |
| Cap. Leases | €29 | €33 | €33 | €21 |
| Total Liabilities | €173 | €244 | €221 | €204 |
| Equity | – | – | – | – |
| Pref Stock | €0 | €0 | €0 | €0 |
| Common Stock | €8 | €7 | €8 | €7 |
| Retained Earnings | -€265 | -€265 | -€256 | -€269 |
| AOCI | -€0 | -€2 | -€9 | €2 |
| Other Equity | €472 | €479 | €462 | €463 |
| Total Equity | €214 | €219 | €205 | €193 |
| Supplemental Information | – | – | – | – |
| Minority Interest | €0 | €0 | €0 | €0 |
| Total Liab. & Tot. Equity | €387 | €463 | €426 | €397 |
| Net Debt | €55 | €110 | -€49 | -€49 |